<DOC>
	<DOCNO>NCT02975050</DOCNO>
	<brief_summary>This study follow objective : • To validate capability μ-Cor System monitor ECG , Heart Rate ( HR ) , Respiration Rate ( RR ) , Posture Activity healthy human subject . The μ-Cor validation demonstrate two body location : 1 . Side location ( left armpit ) study arm 1 , 2 . Front location ( upper leave chest ) study arm 2 An FDA-cleared comparator device use support validation study device .</brief_summary>
	<brief_title>Vital Signs Validation Study μ-Cor System ( ViVUS Validation )</brief_title>
	<detailed_description>This study follow objective : • To validate capability μ-Cor System monitor ECG , Heart Rate ( HR ) , Respiration Rate ( RR ) , Posture Activity healthy human subject . The μ-Cor validation demonstrate two body location : 1 . Side location ( left armpit ) study arm 1 , 2 . Front location ( upper leave chest ) study arm 2 An FDA-cleared comparator device use support validation study device .</detailed_description>
	<criteria>Subject least 21 year age old . Subject willing able sign Informed Consent Form . Subject healthy , able willing complete preparation step study procedure . Exclusion Criteria Female subject know pregnancy unsure pregnancy status . Subjects allergy and/or skin sensitivity electrode hydrogel and/or acrylic base adhesive . Subjects skin breakdown area device placement require . Subjects chronic lung disease asthma . Subjects history cardiovascular disease . Subjects diabetic . Subjects live kidney failure dialysis . Subjects history liver failure . Subjects know malignancy ( i.e . cancer patient ) . Subjects implanted device thoracic region</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>